News
Quidel Reports First Quarter 2020 Financial Results
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first
Humana Jumps 17 Spots on Benchmark List of Top 50 Companies for Diversity
Humana Inc. (NYSE: HUM) rose dramatically on the DiversityInc list of Top 50 Companies for Diversity, jumping 17 spots in making the list for the third year in a row. The list honors leadership in
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to
Veeva to Release Fiscal 2021 First Quarter Results on May 28, 2020
Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter which ended April 30, 2020 after market close on May 28, 2020. Veeva will host a conference call and webcast that day
Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development
Humana-Owned Health Care Facilities Implement New COVID-19 Prevention Standards
Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that its senior-focused primary care subsidiaries Conviva Care Centers, Partners in Primary Care, and Family Physicians
New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized
Pfizer Inc. (NYSE:PFE) today announced detailed results of the first study to show the burden of both invasive and non-invasive Group B Streptococcus infections (GBS) among hospitalized adults in
Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2020.
First quarter 2020 results:
-
Revenue of $859 million, a 2% increase compared to
Bayer – ein langfristiger Kaufkandidat: Börse ist Psychologie!
Noch vor einem Jahr war die Aktie von Bayer (WKN: BAY001) das große Thema unter den Anlegern. Grund hierfür waren immer neue Hiobsbotschaften im Zuge der Übernahme von Monsanto.
Denn eines der
Humana Foundation Commits $50M to Coronavirus Relief and Recovery Efforts
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), today announced it will deploy $50 million in immediate short-term and long-term relief and partner with national and community
Quidel to Present Virtually at the BofA Securities 2020 Health Care Conference
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the
Veeva Announces New Application to Simplify Global Postmarket Surveillance in Medical Device and Diagnostics
Veeva Systems (NYSE: VEEV) today announced Veeva Vault Product Surveillance, a new cloud application for medical device and diagnostics to simplify and standardize the postmarket surveillance
Veeva to Deliver End-to-End Safety Signal and Risk Management
Veeva Systems (NYSE: VEEV) today announced Veeva Vault Signal, the industry’s first solution that seamlessly manages signals from identification through risk evaluation and mitigation. Vault Signal
Veeva CRM Now Integrated with Crossix DIFA Marketing Analytics
Veeva today announced Veeva CRM Boost for DIFA, which will bring Veeva CRM field activity data into the Crossix DIFA marketing analytics platform starting in Q3 2020. The new offering is free to
Spende von Illumina erweitert die Ressourcen des Africa Centre for Disease Control and Prevention für die auf Sequenzierung basierende COVID-19-Kontrolle
Illumina, Inc. (NASDAQ: ILMN) freut sich, bekanntgeben zu dürfen, dass die Kommission der Afrikanischen Union im Namen des Africa Center for Disease Control and Prevention (CDC)
Dexcom Reports First Quarter 2020 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2020.
First Quarter 2020 and COVID-19 Pandemic Response Highlights:
-
Revenue grew 44%
Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Illumina, Inc. (NASDAQ: ILMN) is pleased to announce that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation
PFIZER REPORTS FIRST-QUARTER 2020 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain other components of
Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) systems for people with diabetes, announced today a new patient assistance program to aid current U.S. customers who
GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1)
Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
The board of directors of Pfizer Inc. (NYSE:PFE) today declared a 38-cent second-quarter 2020 dividend on the company’s common stock, payable June 5, 2020 to shareholders of record at the close of
Humana and the National Quality Forum Publish Population Health Paper in the New England Journal of Medicine
Physician leaders from Humana Inc. (NYSE: HUM) and the National Quality Forum (NQF) explore the impact that social, behavioral and environmental factors – such as access to healthy foods, safe
Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 22C3 pharmDx as a companion diagnostic (CDx) to identify patients
Quidel’s Lyra® Direct SARS-CoV-2 Assay Submitted for Emergency Use Authorization for Molecular Detection of COVID-19, Without Extraction Step
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
Gilead Sciences: Einfach kein entscheidender Durchbruch!
Die Aktie von Gilead Sciences (WKN: 885823) steht zuletzt, aufgrund der Covid-19-Pandemie, immer wieder im Mittelpunkt des Anlegerinteresses (wir berichteten). So beflügelte die Aktie kürzlich sogar